SCHEMBL2269197

SCHEMBL2269197

O=C(Nc1cc(Oc2ccccc2)ccc1C(=O)O)c1cc2ccccc2o1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.58
HPGD P15428 2/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
HSD17B10 Q99714 1/20 0.58
RAB9A P51151 12/20 0.56
NPC1 O15118 11/20 0.56
TP53 P04637 6/20 0.56
SMN1; SMN2 Q16637 6/20 0.55
PKM P14618 1/20 0.55
NFKB1 P19838 1/20 0.55
NFKB2 Q00653 1/20 0.55
RELA Q04206 1/20 0.55
GALK1 P51570 1/20 0.54
MAPT P10636 2/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
ATM Q13315 1/20 0.51
POLB P06746 1/20 0.51
MEN1 O00255 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13701152 0.82 RAB9A (0.74) HPGDKDM4EALDH1A1NPSR1RAB9A
SCHEMBL2270361 0.82 RAB9A (0.59) TSHRHPGDNPSR1HSD17B10RAB9A
SCHEMBL19476619 0.81 RAB9A (0.73) TSHRHPGDKDM4EALDH1A1NPSR1
SCHEMBL2275875 0.80 RAB9A (0.56) HPGDKDM4EALDH1A1NPSR1RAB9A
SCHEMBL2271588 0.79 SERPINE1 (0.64) RAB9ANPC1PKMGALK1MAPT
SCHEMBL2274270 0.78 KMT2A (0.54) SMN1; SMN2MAPTMEN1KMT2AHDAC1
SCHEMBL2269797 0.76 SERPINE1 (0.50) GALK1
SCHEMBL2276169 0.76 SERPINE1 (0.60) NPSR1PKMGALK1MAPTMEN1
SCHEMBL2274965 0.76 L3MBTL1 (0.49) NPSR1RAB9AL3MBTL1MEN1KMT2A
SCHEMBL6817708 0.76 RAB9A (0.63) TSHRHPGDKDM4EALDH1A1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999132-B2 Anthranilic acid derivative or salt thereof TOYAMA CHEMICAL CO., LTD. (JP) 2011-08-16 US disclosed
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2009-09-24 US disclosed
EP-1820795-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF TOYAMA CHEMICAL CO., LTD. (JP) 2007-08-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090240052-A1 NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF MMP13, MMP26, MMP11 TSHR 3951/4885HPGD 274/4885KDM4E 1257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.